@inproceedings{inproceedings, title  = {{Is it feasible to conduct a randomised controlled trial of pre-habilitation in multiple myeloma (MM) patients awaiting autologous haematopoietic stem-cell transplantation (AHSCT)? The PREeMPT study}},

 url = {{}},

 year = {{2018}},

 month = {{9}},

 author = {{Snowden J and Keen C and Smith L and Skilbeck J and Ross H and Collins K and Simpson S and Dixey J and Walters S and Greenfield D and Mawson S}},

 volume = {{53}},

 journal = {{BONE MARROW TRANSPLANTATION}},

 pages = {{343-344}},

 note = {{Accessed on 2024/12/22}}}